A. Labial necrotizing fasciitis e Incorrect. Labial necrotizing fasciitis is a rapidly progressive bacterial infection that results in fascial and subcutaneous necrosis of polymicrobial origin, with group A Streptococcus as a common cause. It is usually preceded by an invasive procedure, penetrating injury, or burns. 1 
B.
Herpes zoster e Incorrect. Herpes zoster is caused by reactivation of varicella zoster virus and is common in individuals older than 60 years and immunosuppressed. The prodromal period of dysesthesia is followed by development of grouped vesicles on an erythematous base, classically in a dermatomal distribution.
C. Paraneoplastic pemphigus e Incorrect. Paraneoplastic pemphigus (PNP) is a mucocutaneous blistering disorder seen in association with lymphoproliferative disorders, presenting with severe stomatitis and polymorphous skin lesions. E. DIF microscopy e Incorrect. DIF microscopy is useful in the evaluation of mucocutaneous immunobullous disorders, such as pemphigus vulgaris, bullous pemphigoid, cicatricial pemphigoid, and PNP. These conditions present with desquamative gingivitis, painful ulcerations of the gingiva, buccal and lingual mucosa, or severe stomatitis in the case of PNP. 
E. IV vidarabine

Answers:
A. Famciclovir e Incorrect. Famciclovir is the inactive prodrug of valacyclovir. After oral absorption, famciclovir is deacetylated and oxidized to its active form of valacyclovir. Given that famciclovir, valacyclovir, and acyclovir are nucleoside analogues, none of these would be effective in treating acyclovir-resistant HSV.
B. IV acyclovir e Incorrect. Given the patient's immunosuppressed status and lack of response to 1 week of valacyclovir treatment, concern should be raised about acyclovir resistance. Therefore, IV acyclovir would not be an appropriate treatment.
C. IV foscarnet e Correct. Acyclovir resistance develops with mutations in the viral thymidine kinase gene. IV foscarnet is the most appropriate treatment for this patient because it does not require activation by viral protein kinases. 3, 4 Foscarnet is a phosphonoformic acid, not a nucleoside analogue, and is a noncompetitive inhibitor of viral DNA polymerase. After administration of IV foscarnet, the patient showed rapid clinical improvement over the subsequent week (Fig 1, B) .
D.
IV cidofovir e Incorrect. Cidofovir is a nucleotide analogue, and in its active diphosphate form, it works by inhibiting DNA polymerase. It is approved for treatment of cytomegalovirusinduced retinitis in patients with HIV. Although it also has shown activity in resistant HSV infections, it has not been approved for this indication and has carcinogenic and teratogenic side effects.
E. IV vidarabine e Incorrect. Vidarabine is typically used for treatment of herpes zoster in patients with AIDS and has largely been replaced by more potent agents such as acyclovir and valacyclovir in the treatment of HSV.
